(Q34544679)

2 August 2017

1 reference

title

Review of the safety and efficacy of voriconazole (English)

1 reference

2 August 2017

1 reference

Holly L Hoffman

1

1 reference

2 August 2017

R Chris Rathbun

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

11

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

409-429

1 reference

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Drug interactions of HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Interaction between itraconazole and digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Effect of grapefruit juice on serum voriconazole concentrations in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Evaluation of voriconazole pharmacodynamics using time-kill methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery--case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Efficacy of voriconazole in treatment of murine pulmonary blastomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro susceptibility of Candida dubliniensis to current and new antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro activities of four novel triazoles against Scedosporium spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro activities of 10 antifungal drugs against 508 dermatophyte strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.3.409

10.1517/13543784.11.3.409

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference